109908-85-2

Upstream product

• 109908-83-0 3-(5'-carbomethoxypentanoyl)-5-methoxy-2-methylindole 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 109908-87-4 N-(p-tolylsulfonyl)-3-(5'-carbomethoxypent-1'-enyl)-5-methoxy-2-methylindole 
• 109908-88-5 N-(p-tolylsulfonyl)-3-(5'-carboxypent-1'-enyl)-5-methoxy-2-methylindole 
• 109908-77-2 N-(p-chlorobenzoyl)-3-(5'-carboxypent-1'-enyl)-5-methoxy-2-methylindole 
• 109908-86-3 N-(p-tolylsulfonyl)-3-(5'-carbomethoxy-1'-hydroxypentyl)-5-methoxy-2-methylindole 

Relevant academic research and scientific papers

Metabolic Synthesis of Arylacetic Acid Antiinflammatory Drugs from Arylhexenoic Acids. 2. Indomethacin

Arylacetic acid antiinflammatory drugs can be metabolically produced by β-oxidation of 6-arylhex-5-enoic acid side chain.Such a mechanism provides for an in vivo sustained release of the active principle indomethacin from 6-N-(p-chlorobenzoyl)-2-methylin